CIHR Project Grant

CIHR Project Grant
Name	CIHR Project Grant
Established	2000s
Country	Canada

CIHR Project Grant The CIHR Project Grant is a major Canadian biomedical and health research funding mechanism administered by the Canadian Institutes of Health Research. It supports investigator-initiated and team-based projects across clinical, population, and health services research, connecting researchers, institutions, and stakeholders in Canada and internationally.

Overview

The Project Grant program is administered by the Canadian Institutes of Health Research and operates within the context of federal research funding alongside programs run by Natural Sciences and Engineering Research Council and Social Sciences and Humanities Research Council. It funds projects at institutions such as University of Toronto, McGill University, University of British Columbia, University of Alberta, and McMaster University, and complements provincial initiatives like those of Ontario Ministry of Health and Québec Ministère de la Santé et des Services sociaux. Applicants include principal investigators affiliated with hospitals like Toronto General Hospital, research networks such as Canadian Cancer Trials Group, and consortia linked to agencies like Health Canada. Comparable international schemes include grants from the National Institutes of Health, Medical Research Council (UK), Australian Research Council, and European Research Council.

Eligibility and Application Process

Eligible applicants are typically researchers and clinician-scientists affiliated with recognized institutions such as University Health Network, Sunnybrook Health Sciences Centre, Institut national de la recherche scientifique, or provincial research centers like BC Cancer. Eligibility criteria reference policies of organizations such as Tri-Council Policy Statement and involve institutional certifications with bodies like Research Ethics Board and trial registration with platforms akin to ClinicalTrials.gov. The application process requires a detailed proposal, CVs, and budget justification submitted through systems comparable to ResearchNet and is evaluated in light of mandates from ministries including Health Canada and agencies like Canadian Foundation for Innovation. Deadlines align with fiscal and grant cycles governed by Treasury Board decisions and federal budget announcements.

Peer Review and Evaluation Criteria

Peer review panels draw reviewers from universities and institutes such as Dalhousie University, Université de Montréal, Simon Fraser University, Queen's University, and cross-disciplinary centers including Institute for Clinical Evaluative Sciences. Evaluation criteria emphasize significance, innovation, approach, expertise of the team, and feasibility, reflecting standards used by panels in organizations like Wellcome Trust, Howard Hughes Medical Institute, and Gates Foundation. Reviewers consider prior contributions documented in venues such as The Lancet, Nature Medicine, New England Journal of Medicine, PLOS ONE, and BMJ. Panels may be influenced by frameworks from committees like the Standing Committee on Health (Canada) and by international peer review norms established at conferences including the International Congress on Peer Review and Scientific Publication.

Funding, Budget and Duration

Grants provide multi-year funding with budgets intended to cover personnel, equipment, and operational costs at institutions such as St. Michael's Hospital and SickKids Hospital. Award sizes and durations are set within frameworks similar to those used by NIH R01, MRC Programme Grants, and funders such as Canadian Cancer Society Research Institute, with allocations subject to federal appropriation and institutional overhead policies at universities like University of Calgary. Financial administration follows agreements with offices like Finance Canada and compliance standards tied to agencies including the Office of the Auditor General of Canada. Funding decisions are announced in cycles that align with fiscal reporting at organizations such as Statistics Canada.

Outcomes and Impact

Project Grant-supported research has led to publications in journals like Nature, Science, Cell, JAMA, and Annals of Internal Medicine, and has contributed to innovations implemented at health systems such as Alberta Health Services and Institut universitaire en santé mentale de Québec. Outcomes include new diagnostics, therapies, and policy-relevant evidence cited by bodies like World Health Organization, Pan American Health Organization, and national guideline committees including the Canadian Task Force on Preventive Health Care. Funded investigators often mobilize partnerships with charities such as Heart and Stroke Foundation and industry collaborators like Bristol-Myers Squibb and Pfizer for translation and commercialization at incubators like MaRS Discovery District.

Criticism and Reforms

The program has faced critique from researchers at institutions like University of Ottawa and Laurentian University regarding success rates, administrative burden, and shifts in funding priorities; similar debates have occurred at agencies such as NIH and UK Research and Innovation. Reforms have been influenced by reports from panels including the House of Commons Standing Committee on Health and recommendations from organizations like the Canadian Association of University Teachers and Association of Canadian Medical Colleges. Policy changes have sought to address issues highlighted in editorials in The Globe and Mail and analyses by think tanks such as the Fraser Institute and Institute for Research on Public Policy through measures modeled on practices at European Research Council and National Health and Medical Research Council (Australia).

Category:Canadian medical research funding